Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Boosting certain cell signals can prevent hair loss from cancer treatments.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Certain natural compounds called terpenes may help prevent prostate cancer.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Microneedles help treat hair loss by improving hair surroundings and promoting growth.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Using special RNA to target a mutant gene fixed hair problems in mice.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Calretinin can help identify certain skin structures and tumors.

QLT0267 stops hair follicle cell growth and movement.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Krt6a-Cre transgenic mice help study gene effects on hair follicle development and tumor suppression.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Insulinomas and adrenocortical tumors are common in older ferrets, diagnosed with blood tests and ultrasounds, and treated with medications or surgery.

A new therapy for a skin blistering condition has not been developed yet.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.